This test detects variations in the SLCO1B1 gene. It identifies individuals with a specific drug transporter defect associated with statin-induced myopathy. It assists healthcare providers in selecting a statin that is less likely to cause this adverse event. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.
Hey Practitioners! 
On December 11th, join Dr. Terry Wahls in a free live class where she'll share her groundbreaking methods for managing MS and autoimmune patients. This live session will address your most pressing questions and will take a closer look at treatment options beyond the conventional standards of care. Register here.
Register Here
.svg){kind=small}
.svg){kind=small}
